From the Ocean, to You.

Helping to design the next generation of health products, to bring the untapped and limitless healing power of the ocean to you.

From aspirin, to penicillin, to rapamycin, the natural world has been, and continues to be, a prolific source of medically relevant chemical starting points for groundbreaking therapeutics. Unfortunately, typical approaches in this field are plagued by long-timelines and sample complexity.

Since 2012, Sirenas has been the pioneer and global leader in harnessing computational metabolomics for the discovery of small molecule therapeutic leads from natural sources. Our approach, dubbed ATLANTIS, unleashes advanced computational algorithms on large, proprietary metabolomic and bioassay datasets to rapidly uncover key chemical and biological insights for the small molecules present in complex samples from extremely biodiverse environments.

The end result: the ability to mine a vastly untapped chemical language for new chemical scaffolds that are effective across a broad array of high value targets and disease models. Our insights have revealed both extracts and single compounds that modulate inflammation, pathways in cancer, infectious disease and microbiome dynamics. 

We are now using these findings to help design the next generation of health products, to bring the untapped and limitless healing power of the ocean to you.